Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial
Matthew F. Mart, Leanne M. Boehm, Amy L. Kiehl, Michelle N Gong, Atul Malhotra, Robert L. Owens, Babar Khan, Margaret A. Pisani, Gregory A. Schmidt, R. Duncan Hite, Matthew C. Exline, Shannon S. Carson, Catherine L. Hough, Peter Rock, Ivor S. Douglas, Daniel Feinstein, Robert C. Hyzy, William D. Schweickert, David L. Bowton, Andrew L. Masica, Onur M Orun, Rameela Chandrasekhar, Brenda T. Pun, Cayce Strength, Mark Rolfsen, Pratik P. Pandharipande, Nathan E. Brummel, Christopher G. Hughes, Mayur Patel, Joanna L. Stollings, E. Wesley Ely, James C. Jackson, Timothy D. Girard
Topics & Concepts
MedicineDeliriumPlaceboCritical illnessTerm (time)PsychiatryIntensive care medicineRandomized controlled trialMEDLINEPediatricsInternal medicineAlternative medicineCritically illPhysicsLawQuantum mechanicsPathologyPolitical scienceIntensive Care Unit Cognitive DisordersSepsis Diagnosis and TreatmentFamily and Patient Care in Intensive Care Units